Dapagliflozin-Mepha 5 mg
Dapagliflozin-Mepha 5 mg is a medicine authorised by Swissmedic under authorisation number 69915. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 April 2025 and the authorisation is limited until 08 April 2030. ATC code A10BK01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 69915 |
|---|---|
| Name | Dapagliflozin-Mepha 5 mg |
| Full name | Dapagliflozin-Mepha 5 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BK01 |
| First authorisation | 09 April 2025 |
| Authorisation validity | 08 April 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dapagliflozin-Mepha 5 mg, Filmtabletten | B | 09 April 2025 |
| 2 | Dapagliflozin-Mepha 10 mg, Filmtabletten | B | 09 April 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BK01 | 07.06.2. | B |
| 2 | 98 | Tablette(n) | A10BK01 | 07.06.2. | B |
| 3 | 28 | Tablette(n) | A10BK01 | 07.06.2. | B |
| 4 | 98 | Tablette(n) | A10BK01 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dapagliflozin-Mepha 5 mg authorised in Switzerland?
Yes. Dapagliflozin-Mepha 5 mg is authorised by Swissmedic under authorisation number 69915, data as of 01 September 2026. The authorisation is limited until 08 April 2030.
Which dispensing category does Dapagliflozin-Mepha 5 mg have?
Dapagliflozin-Mepha 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dapagliflozin-Mepha 5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.